<DOC>
	<DOCNO>NCT01907217</DOCNO>
	<brief_summary>Electroconvulsive therapy ( ECT ) powerful antidepressant treatment available often life-saving . There concern , however , standard bitemporal ECT ( commonly use form ECT worldwide ) cause persist retrograde amnesia . However , clinical trial indicate high-dose unilateral ECT may effective bitemporal ECT much less cognitive side-effects . The trial aim test primary experimental hypothesis : High-dose ( 6 x ST ) right unilateral ECT effective ( i.e . inferior ) standard ( 1.5 x ST ) bitemporal ECT severe depression term Hamilton Depression Rating Score ( HDRS ) end treatment course .</brief_summary>
	<brief_title>Enhancing Effectiveness Electroconvulsive Therapy Severe Depression</brief_title>
	<detailed_description>The study two-group parallel design randomise control non-inferiority trial register ( ISRCTN23577151 ) . Consented patient major depressive disorder ( DSM-IV ) randomly allocate course bitemporal ( BT ) ECT ( 1.5 x ST ) high-dose right unilateral ( RUL ) ECT ( 6.0 x ST ) . To facilitate generalizability result , trial take place `` real world '' condition group continue usual care medication treatment phase thereafter . Patients followed-up 12 month complete allocated course ECT . Completion primary outcome depression-rating measure ( i.e . HDRS ) secondary outcome interest ( autobiographical memory , use AMI-SF ) prioritise data collection . Patients , treat clinician raters blind treatment ; clinician administer ECT involve post randomisation assessment formal data analysis . Success blind patient raters assess second final treatment . The trial statistician also blind allocation status . Sample size : In large series ( n = 253 ) depress patient , Petrides et al . ( 2001 ) find mean ( SD ) reduction 24-item HDRS 25.6 ( 9.4 ) treatment bitemporalT ECT ( 1.5 x ST ) . We therefore estimate 69 patient require per treatment group 80 % power demonstrate , use one-sided equivalence t-test 5 % level , mean reduction 24-item HDRS achieve use high-dose RUL ECT 4 point ( i.e . equivalent 3 point 17-item HDRS ) less achieve use standard BT ECT , assume common within-group SD change score 9.4 equal expect group mean change score .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Methohexital</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<criteria>Patients â‰¥18 year diagnose major depressive episode ( DSMIV ) refer ECT Any condition render patient medically unfit general anaesthesia ECT ; treatment ECT previous six month ; dementia Axis 1 diagnosis ; alcohol/other substance abuse previous six month ; inability/refusal consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Electroconvulsive therapy</keyword>
	<keyword>ECT</keyword>
	<keyword>electrode placement</keyword>
	<keyword>effectiveness</keyword>
	<keyword>cognition</keyword>
	<keyword>autobiographical memory</keyword>
</DOC>